FHIR Osiris Implementation Guide
1.1.0 - trial-implementation
This page is part of the OSIRIS FHIR Implementation Guide (v1.1.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Draft as of 2025-04-03 |
{
"resourceType" : "ValueSet",
"id" : "AdverseEventGrade",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet AdverseEventGrade</b></p><a name=\"AdverseEventGrade\"> </a><a name=\"hcAdverseEventGrade\"> </a><a name=\"AdverseEventGrade-en-US\"> </a><p>Ce jeu de valeur (ValueSet) inclut les codes selon les règles suivantes :</p><ul><li>Include ces codes sont définis dans <code>https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf</code> version <code>"5.0"</code><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1</td><td>Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated.</td></tr><tr><td>2</td><td>Moderate; minimal, local or noninvasive intervention indicated; limiting ageappropriate instrumental ADL.</td></tr><tr><td>3</td><td>Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self care ADL</td></tr><tr><td>4</td><td>Life-threatening consequences; urgent intervention indicated.</td></tr><tr><td>5</td><td>Death related to AE.</td></tr></table></li><li>Include ces codes sont définis dans <a href=\"http://terminology.hl7.org/6.2.0/CodeSystem-umls.html\"><code>http://terminology.hl7.org/CodeSystem/umls</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C0439673</td><td>Unknown</td></tr></table></li></ul></div>"
},
"url" : "https://ig-osiris.cancer.fr/ig/osiris/ValueSet/AdverseEventGrade",
"version" : "1.1.0",
"name" : "AdverseEventGrade",
"title" : "Adverse Event Grade Value Set",
"status" : "draft",
"date" : "2025-04-03T15:16:31+02:00",
"publisher" : "institutcancer",
"contact" : [
{
"name" : "institutcancer",
"telecom" : [
{
"system" : "url",
"value" : "http://cancer.fr"
},
{
"system" : "email",
"value" : "osiris@institutcancer.fr"
}
]
},
{
"name" : "Aurélien JOBARD",
"telecom" : [
{
"system" : "email",
"value" : "osiris@institutcancer.fr"
}
]
}
],
"description" : "Adverse event grade",
"compose" : {
"include" : [
{
"system" : "https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf",
"version" : "\"5.0\"",
"concept" : [
{
"code" : "1",
"display" : "Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated."
},
{
"code" : "2",
"display" : "Moderate; minimal, local or noninvasive intervention indicated; limiting ageappropriate instrumental ADL."
},
{
"code" : "3",
"display" : "Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self care ADL"
},
{
"code" : "4",
"display" : "Life-threatening consequences; urgent intervention indicated."
},
{
"code" : "5",
"display" : "Death related to AE."
}
]
},
{
"system" : "http://terminology.hl7.org/CodeSystem/umls",
"concept" : [
{
"code" : "C0439673",
"display" : "Unknown"
}
]
}
]
}
}